Envision Pharma Group

Sustainability Report and Carbon Intensity Rankings

Is Envision Pharma Group doing their part?

Their DitchCarbon score is 60

Envision Pharma Group has a DitchCarbon Score of 60, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage its carbon intensity, suggesting there is room for improvement in reducing emissions. A higher score would demonstrate a stronger commitment to lowering carbon intensity and enhancing sustainability measures.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Envision Pharma Group is part of the services sector, which has a very low carbon intensity ranking compared to other industries. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Envision Pharma Group operates in the United Kingdom, which has a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by reducing its carbon footprint.

Unlock 30+ emissions intelligence data points

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Envision Pharma Group

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

16.15%

...this company is doing 16.15% better in emissions than the industry average.

Envision Pharma Group, founded in 2001 and headquartered in Horsham, operates within the services sector, specifically focusing on the pharmaceutical industry. The company is a pioneer in technology-led scientific communications and global publication planning. They offer a suite of services including strategic consulting, market access, medical communications, and proprietary technology solutions like Datavision®, Visiontracker®, and Clear® to partners in Pharma, Life Sciences, and Biotech.

emission intelligence's platform recommendations for Envision Pharma Group

Envision Pharma Group should foster sustainability practices throughout their supply chain to achieve a significant reduction in their Scope 3 emissions.

Good news, Envision Pharma Group has embraced SBTi commitments

Envision Pharma Group has pledged to set science-based emissions reduction targets through the Science Based Targets initiative (SBTi). This commitment means the company aims to align its carbon reduction strategy with the goals of the Paris Agreement to limit global warming.
Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.